1/149
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Historical figures who contributed to the advancement of science and pharmacy:
Hippocrates
father of medicine
“pharmakon”
scientific systemized medical knowledge
Historical figures who contributed to the advancement of science and pharmacy:
Dioscordes
De Materia Medica
physician and botanist
naturally occurring medicinal materials
Historical figures who contributed to the advancement of science and pharmacy:
Galen
Galenic pharmacy
Galenicals
pharmacist-physician
naturally occurring vegetable drugs and formulations
Historical figures who contributed to the advancement of science and pharmacy:
Paracelsus
specific drug to specific disease
changed pharmacy from botanical science to chemical science
Historical figures who contributed to the advancement of science and pharmacy:
Karl Wilhem
lactic acid, citric acid, oxalic acid, tartairc acid, arsenci acid, glycerin, calomel, benzoic acid, oxygen
Historical figures who contributed to the advancement of science and pharmacy:
Friedrich Serturner
morphine from opium
Historical figures who contributed to the advancement of science and pharmacy:
Joseph Pelletier and Joseph Caventou
quinine, cinchonine, brucine
Historical figures who contributed to the advancement of science and pharmacy:
Joseph Pelletier and Peirre Robiquet
caffeine
Historical figures who contributed to the advancement of science and pharmacy:
Pierre Robiquet
Codeine from opium
Historical figures who contributed to the advancement of science and pharmacy:
Jonathan Roberts
1st hospital pharmacist
Development and purpose of USP and NF:
When was USP created and why?
in 1820 to establish drug standards
Development and purpose of USP and NF:
Pharmakon =
drug
Development and purpose of USP and NF:
poiein =
make
Development and purpose of USP and NF:
What led to the evolution of the USP?
influences of synthetic organic chemistry
Development and purpose of USP and NF:
Pharmacopeia
any recipe/formula/other standards required to make drugs
Development and purpose of USP and NF:
What happened in Mass in 1808?
MA published its own pharmacopeia used by apothecaries to properly fill prescriptions from physicians since it defined the identity of drugs and prep
Development and purpose of USP and NF:
What happened in 1820?
the US pharmacopeial convention was founded in DC by a group of physicians; all states were invited to participate but only 11 came
Development and purpose of USP and NF:
How many drugs were in the first USP? Why?
200
they were deemed “most fully established and best understood”
Development and purpose of USP and NF:
Father of USP?
Dr. Lyman Spalding
Development and purpose of USP and NF:
When was the NF made? by who?
in 1888 by APhA
Development and purpose of USP and NF:
What did the NF include when it was first made?
drugs that were left out of the USP
Development and purpose of USP and NF:
In 1906, the USP and NF standards for _____, _____, and ______ were officially recognized
strength, quality, and purity
Development and purpose of USP and NF:
What happens in 1975?
the USP buys NF and they drop their first combined compendium in 1980
Components of the USP-NF and Central features of a typical drug monograph:
3 components
monograph
general chapters
general notices
Components of the USP-NF and Central features of a typical drug monograph:
monograph
Standards for all drug substances, dosage forms, and compounded preparations (USP). Standards for all excipients (NF).
Components of the USP-NF and Central features of a typical drug monograph:
general chapters
Tests/procedures referred to in multiple monographs are described in detail
Components of the USP-NF and Central features of a typical drug monograph:
General notice
provides definitions of terms used in the monograph
Components of the USP-NF and Central features of a typical drug monograph:
general chapters examples
797, 795, 800
Components of the USP-NF and Central features of a typical drug monograph:
USP 797
sterile compounding
Components of the USP-NF and Central features of a typical drug monograph:
USP 795
nonsterile compounding
3 classifications: simple, moderate, complex
complex: requires special training
USP-NF is preferred source for compounding but if it is not available the next highest grade should be used
defective product log must be kept by the pharmacy and reported to MA board of pharmacy
Components of the USP-NF and Central features of a typical drug monograph:
USP 800
hazardous drugs (sterile and nonsterile compounding)
Compare and Contrast significant drug regulation and control federal laws and their impact:
food and drug act of 1906
required that drugs marketed interstate comply with claimed standards for strength purity and quality
Compare and Contrast significant drug regulation and control federal laws and their impact:
Sherley amendement 1912
Addressed manufacturer’s claims of therapeutic benefit
no more false or misleading claims (would result in seize)
prosecution
Compare and Contrast significant drug regulation and control federal laws and their impact:
Federal Food, Drug, and Cosmetic Act 1938
there is a need for safe administration of drugs after tragedy caused by sulfanilamide
required SAFETY testing before marketing
required product labeling with directions
no drug could be distributed without filing NDA and FDA approval
injunctions
Compare and Contrast significant drug regulation and control federal laws and their impact:
per the food drug and cosmetic act of 1938, what 5 things did the new dug approval process depend on?
ingredients
methods used to evaluate products
standards used to evaluate formulations
preclinical studies
clinical trials
Compare and Contrast significant drug regulation and control federal laws and their impact:
what did the federal food, drug and cometic act of 1938 establish but not require?
established guidelines for safe use of drugs
did NOT require EFFICACY
Compare and Contrast significant drug regulation and control federal laws and their impact:
Durham Humphrey amendment of 1952
no refills without valid prescription
Compare and Contrast significant drug regulation and control federal laws and their impact:
the Durham Humphery amendment clarified dispensing obligations of _____
pharmacists
Compare and Contrast significant drug regulation and control federal laws and their impact:
What did the Durham-Humphrey amendment define?
drugs that cannot be used safely without proper medical supervision and determined what drugs are OTC
Compare and Contrast significant drug regulation and control federal laws and their impact:
the Durham-Humphrey amendment was further supported by which two acts/ amendments?
drug abuse control amendments of 1965 and comprehensive drug abuse prevention act and control act of 1970
Historical events that prompted change in drug regulation:
Thalidomide babies
women used to take thalidomide for morning sickness and then it messed with their babies
led to Kefauver- Harris amendment of 1962
Compare and Contrast significant drug regulation and control federal laws and their impact:
Kefauver-Harris Amendment of 1962
amendment made to the FDC act of 1938
required IND to be filed with FDA
Compare and Contrast significant drug regulation and control federal laws and their impact:
under Kefauver-Harris amendment of 1962 how many days is the FDA given to review for approval of NDA?
180
Compare and Contrast significant drug regulation and control federal laws and their impact:
Kefauver-Harris amendment required that drugs be proven
safe and efficacious (exempted grandfathered drugs which had entered the market between 1906 and 1938)
Compare and Contrast significant drug regulation and control federal laws and their impact:
KH required manufacturers to…
record and report adverse events
Compare and Contrast significant drug regulation and control federal laws and their impact:
KH gave FDA control over
RX drug advertising
Compare and Contrast significant drug regulation and control federal laws and their impact:
KH established
good manufacturing practices
Compare and Contrast significant drug regulation and control federal laws and their impact:
comprehensive drug abuse prevention and control act of 1970
established 5 schedules for drugs subject to abuse
Compare and Contrast significant drug regulation and control federal laws and their impact:
FDAs strongest labeling requirements for high risk medications associated with serious adverse reactions
black box warning
Compare and Contrast significant drug regulation and control federal laws and their impact:
Pregnancy and Lactation Labeling Rule
“use in specific populations”
Compare and Contrast significant drug regulation and control federal laws and their impact:
Drug Listing Act of 1972
NDC
10 digits
Compare and Contrast significant drug regulation and control federal laws and their impact:
Orphan Drug Act of 1983
enabled FDA to promote research and marketing of drugs needed for treating rare diseases
Compare and Contrast significant drug regulation and control federal laws and their impact:
Drug Price Competition and Patent Term Restoration Act of 1984
extension of patent life
Speed of FDA approval of generic drugs
introduced abbreviated New Drug Application
Compare and Contrast significant drug regulation and control federal laws and their impact:
Prescription Drug Marketing Act of 1987
“the Dingell Bell”; drug diversion act
prohibits drug reimportation
sales restrictions
sample distribution
wholesale distributors
Compare and Contrast significant drug regulation and control federal laws and their impact:
Prescription Drug User Fee Act of 1992
allows the fda to accept user fees from drug and biologic companies in return for committing to review new drug applications within certain time frames
Compare and Contrast significant drug regulation and control federal laws and their impact:
The prescription drug user fee act is credited with a more….
rapid application review process and the speedier approval of new drugs
Compare and Contrast significant drug regulation and control federal laws and their impact:
prescription drug user fee act included designated and resources for…
post marketing studies to monitor the continuing safety and efficacy of new drug products
Compare and Contrast significant drug regulation and control federal laws and their impact:
DSHEA of 1994
regulates labeling claims for herbs and dietary supplements such as vitamins, mineral, amino acids, and botanicals
Compare and Contrast significant drug regulation and control federal laws and their impact:
DSHEA legally does NOT…
consider supplements drugs
Compare and Contrast significant drug regulation and control federal laws and their impact:
under DSHEA companies can choose to become…
USP verified meaning they adhere to USP-NF Standards
Compare and Contrast significant drug regulation and control federal laws and their impact:
FDA Modernization act of 1997 was the first…
major overhaul of the FDC Act of 1938
Compare and Contrast significant drug regulation and control federal laws and their impact:
FDA Modernization Act of 1997
Streamlined FDA policies
Codify FDA regulations (next slide)
Expand patient access to investigational treatment for
life-threatening disease
Accelerated approval of new drugs
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Guidelines and Regulations
29
Branches of the FDA:
Code of Federal Regulations (CFR) and the Federal Register (FR)
Title 21 CFR
Volumes 1-8
Volume 9 = DEA
Updated annually
Federal Register (FR) issued each day
Final regulations
Legal notices
FDA:
Drug Product Recall
Manufacturers/Practitioners legally bound to report adverse
reactions to FDA MedWatch Program
class 1 recall
serious/ irreversible harm/ death
class 2 recall
temporary consequences
class 3 recall
not likely to cause adverse health consequences
Branches of the FDA:
CDER
CBER
Center for Drug Evaluation and Research
Center for Biologics Evaluation and Research
Branches of FDA:
CDER - Watch dog
evaluates new drugs for safety and effectiveness before they can be sold
watch for drug problems
monitor drug advertising
protects drug quality
Branches of FDA:
CDER - The review Team
CDER’s Offices of Drug Evaluation
Pharmacologists
Physicians
Pharmacokineticists
Statisticians
Microbiologists
and more
Branches of FDA
CDER- Benefit vs Risk
can determine what are high priority drugs
drugs that offer a significant medical advantage over current therapies
approval of these drugs can be accelerated
Drug Discovery Summary
basically the path a drug travels from lab to cabinet is long and unique. It requires research, molecular modifications, and mechanism based drug design. Drugs can be isolated from nature (plants and animals-vax) or synthesized in a lab
Prodrugs
Levodopa is bioactivated by dopa decarboxylase to the active dopamine
Discovery begins with
the identification of a target disease and potential therapeutic compound
the discovery aspect of drug discovery is the most ____ and _______ ________
most variable and least successful
Nonclinical development-
translates discovery science into therapeutic candidates
it involves modifications, scale-up, purification, test methods and production
studies in animals
clinical development
studied performed in humans
phase 1, 2, 3, and 4
many drugs work by interacting with…
specific cell macromolecules like receptors or enzymes that play a critical role in a physiological or disease process
cellular macromolecules=
small molecules like traditional pharmaceuticals or they can be other proteins =
lock or target
key
key/lock fit can be optimized for
specificity and interaction strength
Nonclinical studies are performed to demonstrate the compounds:
ability to bind with the desired affinity and specificity
has an acceptable safety profile based on tolerability in animals
has a reasonable chance of showing efficacy in humans based on animal findings
used to estimate the starting dose and dose range for clinical trials
single dose toxicology
genotoxicity
reproductive toxicity
cns safety
respiratory safety
bioavailability
pharmacokinetics
efficacy
drug-drug interaction
repeat-dose toxicology
cardiovascular safety
phototoxicity
carcinogenicity
primary pharmacology
secondary pharmacology
primary pharmacology
main point of the drug
studies on the mode of action/ effects in relation to the desired therapeutic effect
secondary pharmacology
endpoints, side effects
studies on the mode of action/ effects NOT in relation to its desired target (general)
purpose of IND
initiate clinical study
negates federal law
documents safety
Defining New in IND:
required anytime a sponsor wishes to conduct a…
clinical trial of an unapproved drug in the US, regardless of whether the drug will be commercially developed
Defining New in IND
an approved drug can also be considered a…
new drug and may therefore require an IND to conduct a clincal trial
Defining New in IND
An IND is required to intiate a clinical trial in the US if the drug is
A new chemical entity
Not approved for the indication under investigation
In a new dosage form
Being given at a new dosage level
In combination with an unapproved drug
primary goal during preclinical development is to
determine if the investigation product is reasonably safe for initial use in humans and if it exhibits activity that justifies further development
the sponsor is focused on collecting information to establish…
the product will NOT expose humans to unreasonable risk in clinical studies
An IND is a series of docs submitted to the FDA when a…
sponsor hopes to test its drug by conducting clinical trials
AN IND is not approved, however, unless FDA says otherwise, 30 days after an IND is submitted…
the company may begin clincial trails in the US
Following intial submisssion…
many additional documents may be submitted to and IND such as IND amendments
IND Contents
administrative
CMC
nonclinical
clinical
IND Review - Pharmacology
Focuses on results of pharmacology and toxicology
testing and attempts to relate test results to human pharmacology
IND Review - Chemistry
Evaluates manufacturing and processing procedures to
ensure the compound is adequately reproducible and stable in its
pure form
IND Review- Clinical
Evaluates the clinical trial protocol to determine if:
1. the subject will be protected from unnecessary risks, and
2. the study design will provide data relevant to safety and effectiveness of the
drug.
sponsor may commence clincal trials after how many days after FDA received FDA submission?
30 days, unless the FDA says otherwise